Power, sample size and adaptation considerations in the design of group sequential clinical trials

DOI10.1093/BIOMET/91.3.507zbMath1113.62090OpenAlexW2315952772MaRDI QIDQ3429959

Tze Leung Lai, Mei-Chiung Shih

Publication date: 20 March 2007

Published in: Biometrika (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1093/biomet/91.3.507

zbMATH Keywords

information boundgroup sequential testfutility boundary

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Optimal stopping in statistics (62L15)

Related Items (14)

Most powerful test sequences with early stopping options ⋮ Bandit Theory: Applications to Learning Healthcare Systems and Clinical Trials ⋮ Generalized Sequential Probability Ratio Test for Separate Families of Hypotheses ⋮ Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials ⋮ Modern sequential analysis and its applications to computerized adaptive testing ⋮ Asymptotically optimal multistage tests of simple hypotheses ⋮ Efficient Adaptive Randomization and Stopping Rules in Multi-arm Clinical Trials for Testing a New Treatment ⋮ Active Postmarketing Drug Surveillance for Multiple Adverse Events ⋮ Beyond boundaries: Gary Lorden’s groundbreaking contributions to sequential analysis ⋮ Asymptotically optimal multistage tests for non-i.i.d. data ⋮ Adaptive enrichment designs for confirmatory trials ⋮ Complementary hypotheses in safety surveillance ⋮ Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes ⋮ Asymptotically Optimal Sequential Design for Rank Aggregation

This page was built for publication: Power, sample size and adaptation considerations in the design of group sequential clinical trials